Clinical Trial: A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers

U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07141199) titled 'A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers' on Aug. 19.

Brief Summary: The objective of this study is to assess the safety, tolerability, pharmacokinetics, and immunogenicity following multiple intravenous (IV) ascending doses of ABBV-8736 in healthy adult participants.

Study Start Date: Aug. 19

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer

Intervention: DRUG: ABBV-8736

Intravenous (IV) Infusion

DRUG: Placebo

IV Infusion

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AbbVie

Published by...